Fingerprint
Dive into the research topics of 'Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically